Blackford Capital Invests in Texas Injection Molding

Blackford Capital (via Davalor) Acquires Industrial Molding Corporation from NN, Inc.

July 3, 2024

Manufacturing

Blackford Capital’s portfolio company Davalor Mold Company acquired Industrial Molding Corporation (IMC) from NN, Inc. as the first add-on for the Davalor platform. The Lubbock, Texas injection-molding business will operate as a separate business unit under Davalor, retaining IMC’s management and expanding Davalor’s precision plastics capabilities across automotive and industrial end markets.

Davalor Mold (Blackford Capital) Acquires Industrial Molding Corporation from NN, Inc.

February 13, 2025

Manufacturing

Davalor Mold Company, LLC, a portfolio company of Blackford Capital, acquired Industrial Molding Corporation from NN, Inc. as the first add-on to the Davalor platform. The acquisition expands Davalor's manufacturing capabilities and leadership bench, supporting continued platform growth and capability expansion.

Blackford Capital Invests in Aqua‑Leisure Industries

January 13, 2021

Consumer Products

Grand Rapids-based private equity firm Blackford Capital announced a majority investment in Aqua‑Leisure Industries, a Boston-area designer, manufacturer and distributor of water-sport and pool leisure consumer products. Blackford said it will support organic growth, expand distribution and pursue add-on acquisitions while the Aqua‑Leisure management team remains in place; financing partners included Mercantile Bank and Muzinich & Co., with Rush Street advising on debt financing.

Bain Capital Acquires Majority Stake in Milacron Injection Molding and Extrusion Business

February 5, 2025

Manufacturing

Bain Capital’s Special Situations team agreed to purchase an approximately 51% majority stake in the Milacron injection molding and extrusion business from Hillenbrand for $287 million, with Hillenbrand retaining roughly 49% and remaining an investor. Bain will have operational control and will partner with Milacron management to accelerate growth while Hillenbrand uses proceeds to pay down debt and focus on its core portfolio.

Arlington Capital Partners Makes Majority Investment in Afton Scientific

January 30, 2024

Pharmaceuticals

Arlington Capital Partners has made a majority investment in Afton Scientific, a Charlottesville-based CDMO specializing in sterile injectable drug manufacturing and related lab/packaging services. The partnership will support Afton's capacity growth and expansion of service offerings while founder and CEO Tom Thorpe remains a material shareholder and will continue to lead the company.

Nelson Miller Group Acquires Injection Works

August 23, 2023

Manufacturing

Nelson Miller Group, a New Water Capital portfolio company, has acquired Injection Works, a Mount Laurel, New Jersey-based custom thermoplastic injection molder. The add-on expands NMG's North American manufacturing footprint and capabilities, enhancing its ability to deliver engineered plastic components and value-added assembly and engineering services to medical, industrial and electrical end markets.